Submitted by reuters8361 in health
Moderna <a href="https://www.reuters.com/markets/companies/MRNA.O" target="_blank">(MRNA.O)</a> should hit the lower end of its sales target for this year as it only needs to tap a small portion of the private market with its COVID vaccine to reach that goal,…